InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,776.63
(
0.44%
)
US TECH 100
19,681.20
(
0.56%
)
Dow Jones
42,400.50
(
0.76%
)
Brent Oil
76.30
(
-1.36%
)
Bitcoin
61,357.56
(
-1.25%
)
Post# of 346450
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

freethemice

Send PM Follow Ignore
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

freethemice

Re: None

Wednesday, 11/28/2012 7:04:57 PM

Wednesday, November 28, 2012 7:04:57 PM

Post# of 346450
Make that 9 trials now. The prostate cancer IST trial, which was suspended while
it was transferred from UC Irvine to Medical University of South Carolina, is now back
on the ClinicalTrials webpage and recruiting patients again. The PI, Michael Lilly, MD
was recruited by MUSC from UC Irvine.

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
This study is currently recruiting participants.
Verified November 2012 by Medical University of South Carolina
Sponsor:
Medical University of South Carolina
Collaborator:
Peregrine Pharmaceuticals
Information provided by (Responsible Party):
Michael Lilly, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT01335204
First received: April 11, 2011
Last updated: November 27, 2012
Last verified: November 2012
History of Changes
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM

Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM

BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM

BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM

CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM

Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM

Start posting your company's news
Only $200 per official company press release!